Mr. Lot CHAN

Assistant Director, Preparatory Office for CMPR, Hong Kong SAR

Mr. Lot Chan studied pharmacy in the UK and Public Health in Hong Kong. He joined the Department of Health more than 30 years ago. For many years he has been involved in regulation of pharmaceutical products. During his service in the Department of Health, Mr. Lot Chan has led the application for the accession to the Pharmaceutical Inspection Co-operation Scheme and the statutory regulation of advanced therapy products.

Currently, Mr. Lot Chan is the Assistant Director of Health, responsible for the preparatory work for the establishment of the Centre for Medical Products Regulation (CMPR), a new Centre under the Department of Health that regulates medicines and medical devices.

Ms. Jacqueline CHENG

Senior Pharmacist, Chinese Medicine Regulatory Office, Department of Health, Hong Kong SAR

Ms. Jacqueline Cheng is a Senior Pharmacist in the Chinese Medicine Regulatory Office of the Department of Health. With training in both Clinical Pharmacy and Chinese Medicines, alongside robust experience in the pharmaceutical manufacturing, she is dedicated to bridging the gap between research and practice.

Jacqueline has worked across key areas of Chinese medicine regulation in the Department of Health, spanning the licensing and inspection of traders, preparing for the permanent Government Chinese Medicines Testing Institute (GCMTI) and serving as the Chair of the Scientific Committee of Hong Kong Chinese Materia Medica Standards Project.

At the GCMTI, she leads the development of advanced macroscopic and microscopic identification methods to guarantee the authenticity and quality of Chinese medicines, and oversees the operation of the Chinese medicines herbarium. Her team’s work bridges traditional heritage with rigorous scientific standards to strengthen the dimensions of healthcare service regulation in Hong Kong.

Prof. Alex HE

Professor, The Hong Kong University of Science and Technology, Hong Kong SAR

Professor Jingwei Alex HE holds a tenured professorship at the Division of Public Policy, The Hong Kong University of Science and Technology (HKUST), where he headed its Institute for Public Policy from 2023 to 2026. He received his PhD from the Lee Kuan Yew School of Public Policy, National University of Singapore, in 2011.

His research specializes in health policy and governance, social welfare reforms, and policy innovation. Professor He has been ranked among the world’s top 2% most-cited scientists since 2021. In Hong Kong’s Research Assessment Exercise (RAE 2020), his research impact case was one of only two to receive a 4-star rating (full score) for “internationally outstanding” impact in the field of public policy. In 2025, the International Public Policy Association (IPPA) conferred upon him its Transition and Developing Economies Award, making him the first Chinese national to receive one of IPPA’s individual recognition awards.

Professor He is also a recipient of the Hong Kong Research Grants Council’s Humanities and Social Sciences Prestigious Fellowship, the Karl Lowenstein Fellowship, the Ronald Coase Institute Fellowship, and the HKUST Faculty Recognition Award.

Prof. Erwin LOH

President, Royal Australasian College of Medical Administrators, Australia

Professor Erwin Loh is the current President of the Royal Australasian College of Medical Administrators, the specialty medical college for medical leaders, and Director of Medical Services at Peninsula Private Hospital, part of Ramsay Health Care. He has had past national medical leadership roles at St Vincent’s and Calvary Health. He is a recognised leader in health ethics, and is appointed by the Federal Health Minister as a member of the Australian Health Ethics Committee (AHEC) of the NHMRC, and a member of the AHEC AI Working Group. He has been an invited speaker on health leadership and AI, and has published peer-reviewed articles and books on these topics, including the textbook “Artificial Intelligence in Medicine” published by Nature Springer. He has adjunct professorships at University of Melbourne, Macquarie University and Monash University. He is a member of the Association of Professional Futurists.

Dr. Muralitharan PARAMASUA

Chief Executive, Medical Device Authority, Ministry of Health Malaysia, Malaysia

Ts. Dr. Muralitharan Paramasua is the Chief Executive of the Medical Device Authority (MDA) under the Ministry of Health Malaysia, a position he has held since February 2023. In this role, he leads the national regulatory agency responsible for ensuring the safety, quality, and performance of medical devices in Malaysia.

With over 20 years of experience in public service, Ts. Dr. Muralitharan has served in key roles across multiple ministries. At the Ministry of Health, he served as an Administrative and Diplomatic Officer, contributing to policy development and regulatory oversight in the healthcare sector. He also served the Ministry of Natural Resources and Environment, where he was involved in international relations and represented Malaysia in various bilateral and multilateral trade negotiations.

Ts. Dr. Muralitharan holds a PhD in International Trade from the University of Malaya, where he also earned his Master’s Degree in Criminal Justice and Bachelor’s Degree in Biohealth Science.

His multidisciplinary expertise bridges science, policy, and international law, positioning him as a strong advocate for regulatory innovation and global collaboration in healthcare.

Dr. Bo Yee SHU

Principal Medical and Health Officer, Office for Regulation of Private Healthcare Facilities, Department of Health, Hong Kong SAR

Dr. SHU Bo Yee is a Specialist in Public Health Medicine and graduate of the Chinese University of Hong Kong. She has served in the Department of Health across the Communicable Disease Branch, the Special Preventive Programme for HIV prevention, and the Centre for Food Safety, where she managed food incidents.

During the COVID-19 epidemic, she contributed to the coordination of Hong Kong residents returning from Hubei Province. For the past 6 years, Dr. Shu has worked in the Office for Regulation of Private Healthcare Facilities, now under the Quality and Standard Division, where she leads efforts in setting standards for the regulation of private healthcare facilities.

Ms. Jooske VOS

Chair of the EPSO Board, Stichting E.P.S.O., The Netherlands

After Ms. VOS's studies in Dutch language and literature, Law, and Economics (master Law, teaching degree Economics), Ms. VOS started her career at the legal department of University of Groningen (Netherlands) in various management and research positions.

Afterwards Ms. VOS held senior positions at various ministries in the Netherlands and worked with legislation and regulation at national and international level.

Ms. VOS has been working for EPSO, the European Partnership for Supervisory Organizations in Health Services and Social Care since 2008, most recently as chairman.

Ms. VOS's recent activities as chairman are aimed at cooperation and information exchange between health and social care inspectorates and regulators in Europe - and since 2019 also between EPSO partners worldwide; this includes among other things EPSO Monthly-Meetings (online), Conferences, Working-groups, Peer-evaluations and other cross-border projects in cooperation with health- and social-care organisations and experts.

Prof. Eng Kiong YEOH

Director, Centre for Health Systems and Policy Research, The Chinese University of Hong Kong, Hong Kong SAR

Professor Yeoh is Professor of Public Health, Director of the Centre for Health Systems and Policy Research at the JC School of Public Health and Primary Care, and Co-director of the Institute of Health Equity. His research is in health systems, services, financing and policy studying how the complex components of health systems interact and interrelate. He has led and collaborated in research projects in health system & policy with academic institutions and networks, World Bank Institute and World Health Organization. His research includes an Extended Study on Regulatory Framework for Healthcare Professions, developing and piloting the 1st accredited registers scheme for allied healthcare professionals, strengthening regulatory requirements for primary care doctors to enhance quality assurance and conducting comparative studies for appropriate regulatory oversight.

He was Secretary for Health, Welfare and Food of the Government of the HKSAR (1999 – 2004), head & the first Chief Executive of the Hong Kong Hospital Authority (1990-1999), with responsibility for transforming the organisation and management of the corporatised public healthcare system.